Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT06837220
- Status
- Recruiting
Conditions
- Nicotine Use Disorder
- Smoking Cessation
- Smoking Cessation Intervention
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 26 Years
- Healthy Volunteers
- Not accepted
Interventions
- Enhanced Courage to Quit — BEHAVIORALParticipants will engage in a version of the smoking cessation treatment "Courage to Quit" that has been optimized for implementation in community behavioral health clinics. The group will run over a period of 3 months, where participants will learn behavioral and cognitive skills for smoking cessation and/or reduction. Special attention will be given to the unique needs of the community, such as technology options or more flexible treatment models. The goal of this intervention is to prove that it is feasible to implement, and can create enhanced engagement and smoking outcomes for adults who smoke (AWS) and have fewer socioeconomic resources.
Study Details
The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, treatment programs and adults who smoke (AWS) in Chicago. This will be accomplished by establishing a community advisory board (CAB) and pilot testing a community-informed smoking cessation treatment within a community behavioral health organization to determine its feasibility after addressing implementation issues.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Pilot InterventionThe participants in this arm will take part in a pilot test of a community-targeted smoking cessation treatment. This treatment will be evidence-based smoking treatment using cognitive behavioral and motivational strategies implemented according to findings from Phase 1 of this study. The original intervention has four core sessions that will be modified accordingly to fit community needs. Participants will complete pre- and post-session questionnaires regarding their smoking status, quit attempts, use of smoking cessation aids, and other surveys.
Primary Outcome Measure
Number of participants who attend the enhanced intervention as assessed by enrollment and sign-in at each session [ Time Frame: 3 months ]
Central Contacts
- Emma Brett, PhD773-834-5341
- Sophie Miller, BS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Chicago | Chicago | Illinois | 60637 | Emma I Brett, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
By research site
Related Studies
- Overcoming Nicotine Dependence to Enable QuittingPHASE1/PHASE2 · Recruiting · Rush University Medical Center · Chicago, Illinois
- Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk BehaviorsRecruiting · Northwestern University · Chicago, Illinois
- New Strategies to Enhance Smoking CessationRecruiting · University of Chicago · Chicago, Illinois
- Multi-Site Trial of Tirzepatide for Smoking CessationPHASE2 · Recruiting · University of Southern California · Los Angeles, California